Jingsong Cao
- Biochemistry top 0.2%
- Lipid metabolism and biosynthesis 15
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 10
- Molecular Biology top 5%
- Peroxisome Proliferator-Activated Receptors 9
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 6
- Immunology top 10%
-
- Pancreatic function and diabetes 7
-
- Pregnancy and Medication Impact 4
-
- Endoplasmic Reticulum Stress and Disease 4
-
- Diet, Metabolism, and Disease 4
Jingsong Cao
78 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 106
- Biochemistry 825
- Oncology 572
- Molecular Biology 1.3k
- Pharmacology 157
- Immunology 333
Countries citing papers authored by Jingsong Cao
This map shows the geographic impact of Jingsong Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingsong Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingsong Cao more than expected).
Fields of papers citing papers by Jingsong Cao
This network shows the impact of papers produced by Jingsong Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingsong Cao. The network helps show where Jingsong Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingsong Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 28 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 48 | |
| 8 | 2019 | 19 | |
| 9 | 2017 | 2 | |
| 10 | 2016 | 55 | |
| 11 | [Effects of autologous plasma and gentamicin on immunophenotype and viability of cytokine-induced killer cells]. | 2014 | 2 |
| 12 | 2013 | 33 | |
| 13 | 2010 | 90 | |
| 14 | 2003 | 53 | |
| 15 | 2002 | 65 | |
| 16 | 2002 | 12 | |
| 17 | 2001 | 72 | |
| 18 | 2000 | 5 | |
| 19 | 2000 | 5 | |
| 20 | 1999 | 42 |
About Jingsong Cao
Jingsong Cao is a scholar working on Biochemistry, Immunology and Transplantation, having authored 78 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lipid metabolism and biosynthesis (15 papers), Drug Transport and Resistance Mechanisms (10 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Pancreatic function and diabetes (7 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Pregnancy and Medication Impact (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Diet, Metabolism, and Disease (4 papers). The work is most often cited by research in Biochemistry (825 citations), Oncology (572 citations) and Molecular Biology (1.3k citations). Jingsong Cao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yuguang Shi, Ruth E. Gimeno, Paul Burn, Mary Vore, John Lockwood, James F. Tobin, Dongmei Li, Aldo D. Mottino, Jian‐Liang Li and Yanfang Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.